InSitu Biologics, Inc.
Pharmaceutical company · Oakdale, Minnesota, United States
InSitu Biologics, Inc. is a pharmaceutical company headquartered in Oakdale, Minnesota, United States. Its earliest recorded incorporation is in 2017. It has reported private securities offerings to the US SEC, most recently $4 million sold in a notice filed in 2025.
InSitu Biologics at a glance
What does InSitu Biologics do?
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $4 million sold (2025).
Frequently asked questions about InSitu Biologics
Where is InSitu Biologics headquartered?
InSitu Biologics, Inc. is headquartered in Oakdale, Minnesota, United States.
What does InSitu Biologics do?
InSitu Biologics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
When was InSitu Biologics founded?
The earliest incorporation on record for InSitu Biologics, Inc. is in 2017, according to public company registers.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences